Skip to content
ViraxImmune™
Products
All
ELISpot Kits
ImmuneSelect Peptide Pools
Recombinant Antibodies
Services
Media
Leadership
Contact Us
Investor Relations
ViraxImmune™
Products
All
ELISpot Kits
ImmuneSelect Peptide Pools
Recombinant Antibodies
Services
Media
Leadership
Contact Us
Investor Relations
£
0.00
0
Cart
Virax COO, Nigel McCracken, Discusses New Data on T Cell Exhaustion in Post-Acute Infection Syndromes with PharmExec.com in Latest Article.
April 17 2025
Read The Full Article